{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T01:37:22Z","timestamp":1755999442816,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.574330","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T04:55:36Z","timestamp":1603256136000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine"],"prefix":"10.3389","volume":"11","author":[{"given":"Imen","family":"Ayadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saidou","family":"Balam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gine","family":"Audran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Bikorimana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issa","family":"Nebie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahamadou","family":"Diakit\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Felger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Spertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampietro","family":"Corradin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Arevalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socrates","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Agnolon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"volume-title":"World Malaria Report 2019","year":"2019","first-page":"p. 232.","key":"B1"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40249-019-0527-7","article-title":"Are malaria elimination efforts on right track? An analysis of gains achieved and challenges ahead","volume":"8","author":"Dhiman","year":"2019","journal-title":"Infect Dis Poverty."},{"volume-title":"Status Report on Artemisinin Resistance and ACT Efficacy","year":"2018","key":"B3"},{"key":"B4","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3201\/eid2404.170141","article-title":"Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016","volume":"24","author":"Ikeda","year":"2018","journal-title":"Emerg Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2305062","DOI":"10.1155\/2018\/2305062","article-title":"Status of artemisinin resistance in Malaria parasite Plasmodium falciparum from molecular analyses of the Kelch13 gene in Southwestern Nigeria","volume":"2018","author":"Oboh","year":"2018","journal-title":"BioMed Res Int."},{"volume-title":"World Malaria Report 2017","year":"2017","first-page":"p. 196","key":"B6"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S1473-3099(18)30348-7","article-title":"The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a worldwide antimalarial resistance network systematic review and individual patient pooled meta-analysis","volume":"18","author":"Commons","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e01965","DOI":"10.1128\/AAC.01965-18","article-title":"Monitoring the efficacy of chloroquine-primaquine therapy for uncomplicated Plasmodium vivax malaria in the main transmission hot spot of Brazil","volume":"63","author":"Ladeia-Andrade","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12936-018-2411-5","article-title":"Chloroquine resistance is associated to multi-copy pvcrt-o gene in Plasmodium vivax malaria in the Brazilian Amazon","volume":"17","author":"Silva","year":"2018","journal-title":"Malaria J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(89)91792-3","article-title":"Plasmodium vivax resistance to chloroquine?","volume":"334","author":"Rieckmann","year":"1989","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4161\/hv.6.1.9677","article-title":"From the circumsporozoite protein to the RTS, S\/AS candidate vaccine","volume":"6","author":"Cohen","year":"2010","journal-title":"Hum Vacc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fimmu.2017.01008","article-title":"S\/AS01E malaria vaccine induces memory and polyfunctional T cell responses in a pediatric African phase III trial","volume":"8","author":"Moncunill","year":"2017","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"VRC 312 study team 2013 protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordm\u00fcller","year":"2017","journal-title":"Nature."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1016\/j.vaccine.2015.09.060","article-title":"Development of vaccines for Plasmodium vivax malaria","volume":"33","author":"Mueller","year":"2015","journal-title":"Vaccine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4269\/ajtmh.2005.73.3","article-title":"Safety and elicitation of humoral and cellular responses in Colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein\u2013derived synthetic vaccine","volume":"73","author":"Herrera","year":"2005","journal-title":"Am J Trop Med Hygiene."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.ijpara.2004.10.009","article-title":"Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein","volume":"34","author":"Herrera","year":"2004","journal-title":"Int J Parasitol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1128\/IAI.01667-06","article-title":"A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites","volume":"75","author":"Yadava","year":"2007","journal-title":"Infect Immun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0119335","DOI":"10.1371\/journal.pone.0119335","article-title":"Recombinant Pvs48\/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes","volume":"10","author":"Ar\u00e9valo-Herrera","year":"2015","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1006\/jmbi.2000.3866","article-title":"Effects of side-chain characteristics on stability and oligomerization state of a de Novo-designed model coiled-coil: 20 amino acid substitutions in position \u201cd\u201d 1","volume":"300","author":"Tripet","year":"2000","journal-title":"J Mol Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/187153007782794371","article-title":"Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogens","volume":"7","author":"Corradin","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e645","DOI":"10.1371\/journal.pone.0000645","article-title":"Rapid identification of malaria vaccine candidates based on \u03b1-helical coiled coil protein motif","volume":"2","author":"Villard","year":"2007","journal-title":"PLoS ONE."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e5419","DOI":"10.1371\/journal.pone.0005419","article-title":"Sequence conservation in Plasmodium falciparum \u03b1-helical coiled coil domains proposed for vaccine development","volume":"4","author":"Kulangara","year":"2009","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0179863","DOI":"10.1371\/journal.pone.0179863","article-title":"Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria","volume":"12","author":"C\u00e9spedes","year":"2017","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/jac\/dkt230","article-title":"An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides","volume":"68","author":"Tong","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e01914","DOI":"10.1128\/mBio.01914-18","article-title":"NadA3 structures reveal undecad coiled coils and LOX1 binding regions competed by meningococcus B vaccine-elicited human antibodies","volume":"9","author":"Liguori","year":"2018","journal-title":"mBio."},{"key":"B27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/bip.22808","article-title":"Platform technology to generate broadly cross-reactive antibodies to \u03b1-helical epitopes in hemagglutinin proteins from influenza A viruses","volume":"106","author":"Jiang","year":"2016","journal-title":"Peptide Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e100440","DOI":"10.1371\/journal.pone.0100440","article-title":"Plasmodium vivax antigen discovery based on alpha-helical coiled coil protein motif","volume":"9","author":"Cespedes","year":"2014","journal-title":"PLoS ONE."},{"key":"B29","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.1016\/j.vaccine.2011.06.122","article-title":"Malaria vaccine candidate: design of a multivalent subunit \u03b1-helical coiled coil poly-epitope","volume":"29","author":"Olugbile","year":"2011","journal-title":"Vaccine."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.vaccine.2008.02.020","article-title":"Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya","volume":"26","author":"Agak","year":"2008","journal-title":"Vaccine."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399498000179","article-title":"Clinical disease, immunity and protection against Plasmodium falciparum malaria in populations living in endemic areas","volume":"1998","author":"Hviid","year":"1998","journal-title":"Expert Rev Mol Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1128\/IAI.00652-09","article-title":"Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c","volume":"77","author":"Olugbile","year":"2009","journal-title":"Infect Immun."},{"volume-title":"World Malaria Report 2018","year":"2018","first-page":"p. 210","key":"B33"},{"volume-title":"Yellow Fever & Malaria Information, by Country, CDC Yellow Book 2018: Health Information for International Travel.","year":"2017","author":"Kathrine","key":"B34"},{"key":"B35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pt.2018.02.006","article-title":"Plasmodium vivax infections of duffy-negative erythrocytes: historically undetected or a recent adaptation?","volume":"35","author":"Gunalan","year":"2018","journal-title":"Trends Parasitol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4269\/ajtmh.17-0254","article-title":"Plasmodium vivax infections over 3 years in duffy blood group negative Malians in Bandiagara, Mali","volume":"97","author":"Niangaly","year":"2017","journal-title":"Am J Trop Med Hygiene."},{"key":"B37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature21038","article-title":"Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution","volume":"542","author":"Rutledge","year":"2017","journal-title":"Nature."},{"key":"B38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jim.2013.11.014","article-title":"Non-specific binding in solid phase immunoassays for autoantibodies correlates with inflammation markers","volume":"403","author":"G\u00fcven","year":"2014","journal-title":"J Immunol Methods."},{"key":"B39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2014.03.013","article-title":"Preventing intense false positive and negative reactions attributed to the principle of ELISA to re-investigate antibody studies in autoimmune diseases","volume":"407","author":"Terato","year":"2014","journal-title":"J Immunol Methods."},{"key":"B40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jim.2019.01.004","article-title":"Reducing the risk of misdiagnosis of indirect ELISA by normalizing serum-specific background noise: the example of detecting anti-FGFR3 autoantibodies","volume":"466","author":"Moritz","year":"2019","journal-title":"J Immunol Methods."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1007\/s00216-018-1172-x","article-title":"Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors\u2014a requisite for correct data evaluation","volume":"410","author":"Haberland","year":"2018","journal-title":"Anal Bioanal Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12951-017-0295-0","article-title":"The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria","volume":"15","author":"Karch","year":"2017","journal-title":"J Nanobiotechnol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.574330\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T04:55:39Z","timestamp":1603256139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.574330\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2020.574330"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.574330","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"article-number":"574330"}}